The Form 4 filing, an SEC report of insider stock transactions, was filed on November 18, 2026. It lists November 16, 2026, as the earliest sale date and November 17 as the latest.
Roivant Sciences Ltd. (ROIV) is listed in the healthcare sector and biotechnology industry. Keith S. Manchester is a director.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 7 |
| Shares Transacted | 1,381,762 |
| Price | $38.75 |
| Total Transaction Value | $53,536,738.01 |
| Insider | |
| Ticker Symbol | ROIV |
| Company | Roivant Sciences Ltd. |
| Insider Name | MANCHESTER KEITH S |
| Insider Title | Director |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales recorded under SEC transaction code S, which identifies a sale. All seven reported transactions concern one director in one filing.
What was the average price of the transaction?
The average price was $38.75 per share, rounded to the nearest cent. This figure covers all seven sales; separate prices for each transaction were not provided.
How did this transaction affect the insider's holdings?
He sold 1,381,762 shares and reported zero shares owned afterward. The shares sold made up 100.00% of the reported balance before the sales. The scope of that balance is not provided, so the zero figure does not establish whether he has shares in other accounts.
What's the total transaction value?
The total value was $53,536,738.01 for all seven sales combined, stated to the nearest cent.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnote text was not provided, so any further terms or explanations in those notes remain unknown.
For research purposes only; not investment advice.